Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Hikma Pharmaceuticals PLC has agreed to acquired substantially of all the assets of the generic injectables manufacturing site in Bedford, Ohio, of Ben Venue Laboratories, Inc., part of the Boehringer Ingelheim. Hikma had recently closed on...

Accelerator Corporation, a life-sciences investment fund based in Seattle, has closed on $51.1 million in capital to expand its operations to New York City at the Alexandria Center for Life Science in Manhattan's East Side Medical...

Roche reports that the European Commission has approved Gazyvaro (obinutuzumab) in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia who have comorbidities making them...

Zealand Pharma, a Copenhagen-based company specializing in the discovery, design, and development of peptide medicines, and Boehringer Ingelheim have formed a new global exclusive research and development collaboration. The collaboration covers a...

Health Canada, the national regulatory authority of Canada, issued a summary report of its inspection conducted in June 2014 of ID Biomedical Corporation's, a subsidiary of GlaxoSmithKline, manufacturing facility located in Sainte-Foy, Quebec....

GlaxoSmithKline plc reports that the US Food and Drug Administration (FDA) has approved Flonase Allergy Relief (fluticasone propionate 50 mcg spray) as an over-the-counter treatment for temporary relief of the symptoms of hay fever or upper...